BRUSSELS - The European Commission is taking the British/Swedish pharmaceutical company AstraZeneca to court over delivery shortfalls of its coronavirus vaccine, the European Commission said Monday.
"The commission has started last Friday a legal action against the company AstraZeneca on the basis of breaches of the advanced purchase agreement," EU spokesman Stefan De Keersmaecker said.
"Some terms of the contract have not been respected and the company has not been in a position to come up with a reliable strategy to ensure the timely delivery of doses," De Keersmaecker said.
"What matters to us in this case is that we want to make sure that there's a speedy delivery of a sufficient number of doses that European citizens are entitled to, and which have been promised on the basis of the contract," he said.
The commission's representative indicated that the 27 EU member states are fully aligned in their support of this procedure.
The case will be heard in a Belgian court.
AstraZeneca has so far delivered just 31 million of the 120 million doses it had promised to the EU. It has warned it will likewise provide just 70 million of the 180 million more meant to be delivered over the rest of this year.